Arkolith/Insider Trading/SUPN/Form 4

Mottola Frank

SVP, Chief Tech. Ops. OfficerSUPERNUS PHARMACEUTICALS, INC. (SUPN) · full profile →Form 4 · filed Feb 25, 2026
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
9
6 non-derivative · 3 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Feb 24, 2026Tax withholding(F)368$50.86$19K17K
Feb 24, 2026Grant(A)1K—$018K
Feb 24, 2026Tax withholding(F)670$50.86$34K17K
Feb 24, 2026Grant(A)1K—$017K
Feb 24, 2026Grant(A)750—$017K
Feb 24, 2026Tax withholding(F)603$51.35$31K16K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Feb 24, 2026Disposed to issuer(D)1K—$03K
Feb 24, 2026Disposed to issuer(D)1K—$03K
Feb 24, 2026Disposed to issuer(D)750—$00

Transaction Codes

F
Shares withheld for taxes
A
Grant / award
D
Disposition to the issuer

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001804567-26-000004) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML